Advanced searches left 3/3

Cardiogenic - Europe PMC

Summarized by Plex Scholar
Last Updated: 10 January 2023

* If you want to update the article please login/register

Impact of time to diagnosis on the occurrence of cardiogenic shock in MIS-C post-COVID-19 infection.

History of a multisystem inflammatory disorder in children includes diagnostic delay, which may be correlated with severity. Methods A single-center prospective cohort observational study was conducted at a tertiary care hospital between May 2020 and July 2022. Children in the World Health Organization's MIS-C guidelines were accepted. The diagnosis of cardiogenic shock was 89% and a specificity of 77%, with age > 8 years and NT-proBNP increasing the specificity to 91% to 91%. Age 8. 8 years [aHR 0. 34 ], short distance to tertiary care hospital [aHR 0. 27 ], and the late period of the COVID-19 pandemic [aHR 2. 48 ]. Conclusions Time to Diagnose u2265 6 days was not associated with cardiogenic shock in MIS-C.

Source link: https://europepmc.org/article/MED/36607546


Trends and outcomes of cardiogenic shock in Asian populations compared with non-Asian populations in the US: NIS Analysis (2002-2019).

Background information on the effects of cardiogenic shock in Asian populations is uncertain. In comparison to non-Asians in the United States, we want to investigate the clinical outcomes of CS in Asia's population. In comparison to non-Asians, the in-hospital mean cost of hospitalization rose in Asian populations with CS. Compared to non-Asians, the use of Impella and left ventricular assist systems made no difference in the use of extracorporeal membrane oxygenation in comparison to non-Asians. Conclusions Conclusion In comparison to non-Asians, Asian populations with CS have higher mortality, increased demand for IABP, and higher mean cost of hospitalization relative to non-Asians.

Source link: https://europepmc.org/article/MED/36597921


Bridging Strategies and Cardiac Replacement Outcomes in Patients with Acute Decompensated Heart Failure-Related Cardiogenic Shock.

Aims To report the results of bridging strategies in patients with acute decompensated heart failure-related cardiogenic shock bridged to a durable left ventricular assist device or heart transplant. Methods and findings Durable LVAD or HTx recipients from 2014 to 2019 with pre-operative ADHF-CS were identified in the Society of Thoracic Surgeons Adult Cardiac Surgery Database and stratified by bridging strategy. Among the 8777 patients with pre-operative CS, 8777 had ADHF-CS. LVAD recipients were more frequent in adverse post-operative outcomes than HTx recipients. Conclusion – Patients with ADHF-CS bridged to HTx or durable LVAD had the highest risk of death and hospitalization during index hospitalization in those bridged with VA-ECMO, followed by catheter-based TMCS, IABP, and medical therapy. Patients with long-lived LVAD had higher incidences of post-operative complications than those who received HTx. To determine optimal bridging strategies in patients with ADHF-CS, prospective clinical trials are required.

Source link: https://europepmc.org/article/MED/36597721


Selection of percutaneous mechanical circulatory support in cardiogenic shock: patient-specific considerations and insights from contemporary clinical data.

Intra-aortic balloon pumps may have an effect on early cardiogenic shock but not so much in stage C-E shock, where percutaneous ventricular assist systems increase cardiac strength/index and survival in certain subsets. Summary of Graded Increasing PMCS support from 2005 to SCAI stage B shock patients onwards should be considered, with the choice of assistance that is appropriate to local experience and aspired trajectory of hemodynamic and metabolic compromise.

Source link: https://europepmc.org/article/MED/36200273


Thyrotoxicosis-Induced Cardiogenic Shock: Acute Management Using a Multidisciplinary Approach

Heart failure and cardiomyopathy has been described as uncommon yet life-threatening complication of thyrotoxicosis or thyroid storm. However, if cardiac function is not known or requires a multidisciplinary care team to investigate it, the treatment of thyrotoxicosis with non-cardioselective beta-blockers has been implicated in the formation of significant decompensation and even cardiogenic shock. The Burch-Wartofsky Score was > 45, and the thyroid function test revealed significant TSH levels, which was significantly reduced. With mild global hypokinesis and a reduced left ventricular ejection percentage, two-dimensional echocardiography performed afterward was helpful for four-chamber dilation with mild global hypokinesis and reduced left ventricular ejection fractions, with mild global hypokinesis and reduced left ventricular ejection fraction. This case illustrates the importance of a multidisciplinary team approach in the acute management of thyrotoxicosis-related cardiogenic shock, as the patient's symptoms were instrumental in assisting the patient in recovering from the acute phase of the disease.

Source link: https://europepmc.org/article/MED/PMC9779909


Mechanical ventilation in patients with cardiogenic pulmonary edema: a sub-analysis of the LUNG SAFE study.

Background Patients with acute respiratory dysfunction exacerbated by cardiogenic pulmonary edema may need mechanical ventilation, which can cause more lung damage. Patients from the LUNG SAFE cohort, a multicenter prospective cohort study of patients with mechanical ventilation, were analyzed. According to researchers, the ICU and hospital mortality rates were 34% and 40%. Patients undergoing mechanical ventilation on ICU day 1 had a subgroup ventilated with high pressures, with a reduced likelihood of being released alive from the ICU and raised hospital mortality, according to a Latent mixture analysis. Conclusions: Patients with CPE who are intensively ventilated have higher airway pressures, which are correlated to mortality.

Source link: https://europepmc.org/article/MED/36567347


Thyrotoxicosis-Induced Cardiogenic Shock: Acute Management Using a Multidisciplinary Approach.

Heart failure and cardiomyopathy have been identified as an infrequent yet life-threatening complication of thyrotoxicosis or thyroid storm. Both thyrotoxicosis-induced cardiomyopathy and cardiogenic shock have been reported to be two of the leading causes of sudden death in adults. However, the use of thyrotoxicosis with non-cardioselective beta-blockers has been implicated in severe decompensation and even cardiogenic shock, as well as cardiac arrest, which often requires a multidisciplinary care team to deal with it. We have highlighted the case of a 63-year-old male with a history of hyperthyroidism who presented to the emergency room with persistent shortness of air. This case illustrates the sensitivity of a multidisciplinary team approach to acute care of thyrotoxicosis-induced cardiogenic shock, as the patient's treatment was instrumental in assisting the patient in recovering from the acute phase of the disease.

Source link: https://europepmc.org/article/MED/36570110


The residual risks associated with atherothrombosis of recurrent ischemic stroke (IS) after non-cardiogenic IS.

Recurrent ischemic stroke is one of the most common causes of disability and death worldwide. Patients with recurrent IS have more frequent neurological disease and longer average hospital stay, as well as heavier family and socioeconomic burden in comparison to survivors of the initial non-cardiogenic IS. Although receiving evidence-based management in accordance with guideline, patients suffering from non-cardiogenic IS and those receiving optimum care remain at substantial residual risks for cerebrovascular events recurrence. With this context, the identification and quantification of RRs associated with disease heterogeneity as well as individualized treatment strategies based on risk stratification are both feasible in the prevention of substantial stroke burdens that people unceasingly face.

Source link: https://europepmc.org/article/MED/36567291


Massive post-infarction ventricular septal rupture complicaing cardiogenic shock with long term veno-arterial extracorporeal membrane oxygenation support.

a rare but significant condition causing cardiogenic shock is ventricular septal rupture following acute myocardial infarction. We report on a case of success with extracorporeal membrane oxygenation for preserving haemodynamic equilibrium preoperative and awaiting surgical repair of a VSR patient in severe CS. Case study A 57-year-old man with AMI is complicated by severe CS as a result of a huge VSR. The ventricular septal defect was effectively repaired and weaning from the ECMO on the 31th day after ECMO's inception. Discussion This case report shows that it may be possible to use long-term ECMO preoperative to delayed surgery, resulting in better outcomes in cases of large VSR patients with hemodynamically impaired patients after AMI. Conclusion This case illustrates the possibility of preoperative use of a long-term VA-ECMO as a bridge to surgical reconstruction of a VSR patient with AMI in severe CS.

Source link: https://europepmc.org/article/MED/36541675


Outcomes among ST-Elevation Myocardial Infarction (STEMI) patients with cardiogenic shock and COVID-19: A nationwide analysis.

Patients and hospital level confounders were adjusted for inpatient and hospital level confounders, thus adjusting for patient and hospital level confounders, STEMI-CS patients' concomitant COVID-19 infection was found to be a predictor of overall hospital mortality in comparison to those without COVID-19. Patients with concomitant COVID-19 disease, coronary artery bypass graft, extracorporeal membrane oxygenation, percutaneous and robust left ventricular catheterization, renal replacement therapy, and similar hospital lengths of stay were all found in-hospital use for percutaneous coronary intervention, coronary artery bypass graft, extracorporeal membrane oxygenation, percutaneous and durable left ventricular pump, renal replacement therapy, mechanical ventilation, as well as similar hospital lengths of stay. Conclusion Concomitant COVID-19 infection was linked to increased in-hospital mortality among patients with cardiogenic shock related to STEMI, but patients with STEMI-related cardiovascular disease had elevated in-hospital mortality rates, as well as hospital lengths.

Source link: https://europepmc.org/article/MED/36570777

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions